Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System

被引:12
|
作者
Borja-Hart, Nancy L. [1 ]
Benavides, Sandra [1 ]
Christensen, Crystal [1 ]
机构
[1] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA
关键词
Gardasil; human papillomavirus; pediatrics; VAERS; PARTICLE VACCINE; QUADRIVALENT VACCINE; UNITED-STATES; TYPE-16; IMMUNOGENICITY; ADOLESCENTS; TRIAL; WOMEN;
D O I
10.1345/aph.1L492
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine.
引用
收藏
页码:356 / 359
页数:4
相关论文
共 50 条
  • [21] Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
    Woo, Emily Jane
    Moro, Pedro L.
    VACCINE, 2022, 40 (07) : 1026 - 1030
  • [22] Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013
    Moro, Pedro L.
    Harrington, Theresa
    Shimabukuro, Tom
    Cano, Maria
    Museru, Oidda I.
    Menschik, David
    Broder, Karen
    VACCINE, 2013, 31 (43) : 4984 - 4987
  • [23] Human papillomavirus vaccine: now for boys too?
    Jenson, Hal B.
    Baltimore, Robert S.
    CURRENT OPINION IN PEDIATRICS, 2011, 23 (01) : 78 - 84
  • [24] Safety of Booster Doses of Coronavirus Disease 2019 (COVID-19) Vaccine in Pregnancy in the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Olson, Christine K.
    Zhang, Bicheng
    Marquez, Paige
    Strid, Penelope
    OBSTETRICS AND GYNECOLOGY, 2022, 140 (03) : 421 - 427
  • [25] Adverse effects of the human papillomavirus vaccine
    Torrecilla Rojas, M. Amparo
    Pedregal Gonzalez, Miguel
    Garcia Rodriguez, Fermin
    Ruiz Fernandez, Josefa
    ATENCION PRIMARIA, 2011, 43 (01): : 5 - 9
  • [26] Facial paralysis and vaccinations: a vaccine adverse event reporting system review
    Ahsanuddin, Salma
    Nasser, Wissam
    Roy, Savannah C.
    Povolotskiy, Roman
    Paskhover, Boris
    FAMILY PRACTICE, 2022, 39 (01) : 80 - 84
  • [27] Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics' impact
    Almadani, Ohoud A.
    Alshammari, Thamir M.
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (12) : 1725 - 1735
  • [28] COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
    Zhang, Bing
    Yu, Xiao
    Liu, Jinxing
    Liu, Jinbao
    Liu, Pengfei
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [29] Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System
    Bonaldo, Giulia
    Montanaro, Nicola
    Vaccheri, Alberto
    Motola, Domenico
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 1912 - 1917
  • [30] The Prophylactic Role for the Human Papillomavirus Quadrivalent Vaccine in Males
    Yancey, Abigail M.
    Pitlick, Jamie M.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (7-8) : 1314 - 1318